Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record.

Salmeterol, a novel, long‐acting β2‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

Open access
Ball, D.I., Brittain, R.T., Coleman, R.A., Denyer, L.H., Jack, D., Johnson, M., Lunts, L.H.C., Nials, A.T., Sheldrick, K.E., Skidmore, I.F. · 1991 · British Journal of Pharmacology

Abstract

Salmeterol, a novel, long‐acting β‐adrenoceptor agonist, has been compared with isoprenaline and salbutamol for activity in vitro on a range of β‐adrenoceptor containing preparations from laboratory animals and man, and in vivo for bronchodilator activity in the conscious guinea‐pig. Salmeterol, like isoprenaline and salbutamol, relaxed preparations of both guinea‐pig trachea (contracted by prostaglandin (PG)F 2α or electrical stimulation) and human bronchus (contracted by PGF 2α) in a concentration‐related fashion. Salmeterol was of similar potency to isoprenaline and more potent than salbutamol on both airway preparations. Relaxant responses of superfused guinea‐pig trachea and human bronchus to isoprenaline and salbutamol declined rapidly when the agonists were washed from the tissues, with complete recovery within 10 min, whereas responses to salmeterol were more persistent. In electrically‐stimulated guinea‐pig trachea preparations, inhibition by salmeterol persisted for periods of up to 12 h, despite continuous superfusion with agonist‐free medium. However, these persistent responses were rapidly and fully reversed by the β‐adrenoceptor blocking drug, propranolol (0.1 μ m). In further studies, on guinea‐pig trachea, propranolol caused concentration‐related parallel, rightward shifts of salmeterol concentration‐effect curves, yielding a pA 2 of 9.0. The slope of the Schild plot was 1.02. Another β‐adrenoceptor blocking drug, sotalol (10 μ m), also fully and rapidly reversed established submaximal responses to salmeterol in superfused guinea‐pig trachea. However, after administration of sotalol was stopped, the antagonism waned, and salmeterol responses were reasserted without the addition of further agonist. In the β 1‐adrenoceptor containing preparation, rat left atria, isoprenaline exhibited potent, concentration‐related, positive inotropic activity, whereas salbutamol and salmeterol were at least 2000–5000 fold less potent, and appeared to be partial agonists. At a concentration of 72μ m, salmeterol exhibited weak antagonism of isoprenaline‐induced increases in atrial force of contraction. This antagonism was less marked than that caused by salbutamol (42 μ m). On the guinea‐pig isolated gastric fundus strip, a putative β 3‐adrenoceptor containing preparation, salbutamol and salmeterol had only modest agonist activity, being 20–30 fold less potent than isoprenaline and the selective β 3‐adrenoceptor agonist, BRL 35135. In conscious guinea‐pigs, inhaled salmeterol and salbutamol were approximately equipotent in causing dose‐related bronchodilatation. Whereas the duration of action of salbutamol at its threshold‐effective dose was less than 90 min, the responses to a similarly effective dose of salmeterol were well‐maintained for at least 6 h. Salmeterol is therefore a potent and selective β 2‐adrenoceptor agonist with a remarkably long duration of action in isolated superfused airways smooth muscle. It also causes persistent bronchodilatation in vivo, in the guinea‐pig, when administered by the inhaled route.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1991.tb12486.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 185

Metadata

Authors
Ball, D. I., Brittain, R. T., Coleman, R. A., Denyer, L. H., Jack, D., Johnson, M., Lunts, L. H. C., Nials, A. T., Sheldrick, K. E., & Skidmore, I. F.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1991-11
Volume
104
Issue
3
Pages
665-671
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2022551713
Cited by
185
References
0
FWCI
5.33
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Salmeterol, a novel, long‐acting β2‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. https://app.cochat.ai/papers/10.1111/j.1476-5381.1991.tb12486.x
The paper
Ball, D. I., Brittain, R. T., Coleman, R. A., Denyer, L. H., Jack, D., Johnson, M., Lunts, L. H. C., Nials, A. T., Sheldrick, K. E., & Skidmore, I. F. (1991). Salmeterol, a novel, long‐acting β2‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1991.tb12486.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.